Historically, the US, and, in particular, the NASDAQ market, has been the predominant place for IPOs of life sciences and healthcare companies. However, 2018 may be the year in which things start to change....more
3/13/2018
/ Capital Markets ,
CFDA ,
China ,
Health Care Providers ,
Hong Kong ,
Hong Kong Stock Exchange ,
Institutional Investors ,
Life Sciences ,
Listing Rules ,
Listing Standards ,
New Rules ,
NYSE ,
Regulatory Oversight
China’s open door policy is further opening up to welcome the world for business. The country is now building a landmark megalopolis on its southern coast with the name the “Greater Bay Area” (the “GBA”). ...more
2/13/2018
/ Capital Markets ,
CEPA ,
Economic Development ,
Emerging Growth Companies ,
Financial Institutions ,
Foreign Corporations ,
Hong Kong ,
Innovation ,
International Tax Issues ,
Subsidiaries ,
Transportation Industry